BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7548507)

  • 1. Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: case report.
    Schmid M; Samonigg H; Stöger H; Auer H; Sternthal MH; Wilders-Truschnig M; Reisinger EC
    Clin Infect Dis; 1995 Jun; 20(6):1543-6. PubMed ID: 7548507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-needle aspiration diagnosis of hydatid cyst.
    Firpi RJ; Lozada LR; Torres EA; Villamarzo G; Lobera A
    P R Health Sci J; 1999 Jun; 18(2):129-31. PubMed ID: 10461319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical-radiological evaluation of benzimidazoles in the management of Echinococcus granulosus cysts.
    Ellis M; von Sinner W; Al-Hokail A; Sieck J
    Scand J Infect Dis; 1992; 24(1):1-13. PubMed ID: 1589713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological changes of larval Echinococcus multilocularis in mice treated with albendazole or mebendazole.
    Nakaya K; Oomori Y; Kutsumi H; Nakao M
    J Helminthol; 1998 Dec; 72(4):349-54. PubMed ID: 9858633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydatid disease: the alveolar variety in Australia. A case report with comment on the toxicity of mebendazole.
    Braithwaite PA; Thomas RJ; Thompson RC
    Aust N Z J Surg; 1985 Oct; 55(5):519-23. PubMed ID: 3868420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sonographic changes of hydatid cyst of the liver after treatment with mebendazole and albendazole.
    Singcharoen T; Mahanonda N; Powell LW; Baddeley H
    Br J Radiol; 1985 Sep; 58(693):905-7. PubMed ID: 3916070
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience in the chemotherapy of severe, inoperable echinococcosis in man.
    Todorov T; Vutova K; Mechkov G; Tonchev Z; Georgiev P; Lazarova I
    Infection; 1992; 20(1):19-24. PubMed ID: 1563807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current interventional strategy for the treatment of hepatic alveolar echinococcosis.
    Vuitton DA; Azizi A; Richou C; Vuitton L; Blagosklonov O; Delabrousse E; Mantion GA; Bresson-Hadni S
    Expert Rev Anti Infect Ther; 2016 Dec; 14(12):1179-1194. PubMed ID: 27686694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mebendazole treatment of Echinococcus granulosus infection. Report of a case.
    Petersen E; Thorén G; Bergquist R
    Am J Trop Med Hyg; 1983 Sep; 32(5):1071-4. PubMed ID: 6625063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzimidazoles in the treatment of alveolar echinococcosis: a comparative study and review of the literature.
    Reuter S; Jensen B; Buttenschoen K; Kratzer W; Kern P
    J Antimicrob Chemother; 2000 Sep; 46(3):451-6. PubMed ID: 10980173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates.
    Franchi C; Di Vico B; Teggi A
    Clin Infect Dis; 1999 Aug; 29(2):304-9. PubMed ID: 10476732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of continuous mebendazole therapy in alveolar hydatid disease--with a summary of a ten-year clinical trial.
    Rausch RL; Wilson JF; McMahon BJ; O'Gorman MA
    Ann Trop Med Parasitol; 1986 Aug; 80(4):403-19. PubMed ID: 3539043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of alveolar echinococcosis with benzimidazoles. A prospective long-term study].
    Reuter S; Kratzer W; Kurz S; Wellinghausen N; Kern P
    Med Klin (Munich); 1998 Aug; 93(8):463-7. PubMed ID: 9747101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of response to chemotherapy of human cystic echinococcosis.
    Todorov T; Vutova K; Mechkov G; Petkov D; Nedelkov G; Tonchev Z
    Br J Radiol; 1990 Jul; 63(751):523-31. PubMed ID: 2202480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term mebendazole therapy may be parasitocidal in alveolar echinococcosis.
    Ammann RW; Fleiner-Hoffmann A; Grimm F; Eckert J
    J Hepatol; 1998 Dec; 29(6):994-8. PubMed ID: 9875648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of experimental alveolar echinococcosis: comparative study of mebendazole, isoprinosine and a mebendazole isoprinosine association.
    Sarciron ME; al-Nahhas S; Walbaum S; Raynaud G; Petavy AF
    Trop Med Parasitol; 1991 Dec; 42(4):417-9. PubMed ID: 1724571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term benzimidazole treatment of alveolar echinococcosis with hematogenic subcutaneous and bone dissemination.
    Scheuring UJ; Seitz HM; Wellmann A; Hartlapp JH; Tappe D; Brehm K; Spengler U; Sauerbruch T; Rockstroh JK
    Med Microbiol Immunol; 2003 Nov; 192(4):193-5. PubMed ID: 12684758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human alveolar echinococcosis: an emerging zoonosis in Hungary and Europe].
    Sréter T; Széll Z; Varga I
    Orv Hetil; 2004 Aug; 145(32):1655-63. PubMed ID: 15384864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspectives in the diagnosis of Echinococcus disease.
    Munzer D
    J Clin Gastroenterol; 1991 Aug; 13(4):415-23. PubMed ID: 1918847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First experience in the treatment of human hydatid disease with mebendazole.
    De Rosa F; Teggi A
    Drugs Exp Clin Res; 1985; 11(12):875-8. PubMed ID: 3836117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.